Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Nov. 18, 1997

COX-2 antisense therapy for rheumatoid arthritis

Nov. 18, 1997

Improvement in early and established arthritis with antiangiogenic therapy

Nov. 18, 1997

Potential of rhM-CIF in rheumatoid arthritis suggested by animal studies

Nov. 18, 1997

New MMP inhibitors from Pharmacia & Upjohn

Nov. 18, 1997

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

T-614, a new NSAID that appears to act as a lysosomal protease inhibitor

Nov. 14, 1997

KE-298 suppresses MMP production in RA synoviocytes

Nov. 14, 1997

Selective collagenase 3 inhibitor shows promise for osteoarthritis

Nov. 14, 1997

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...